Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Brazil

Novo Nordisk Opens Insulin Plant

May 2007 | Company News Alert

Danish insulin maker Novo Nordisk opened a US$200mn new insulin plant representing one of the largest single recent investments in the Brazilian pharmaceutical market as the company looks to increase its leading market share in the growing insulin markets of Brazil and the wider Latin American region. The company is betting that its additional capacity at the sector can see off efforts to boost domestic manufacturing capacity at Brazilian state-owned player Farmanguinhos as well recent high-profile multinational launches of diabetes care

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.

Related Insight Articles
InVentiv Off-Shores

Industry / Brazil Following in the footsteps of drug developers that are recognising the attraction of emerging markets as a base for clinical trials, Inventiv Health, a leading provider of clinical trials support services...
March 2008
InVentiv Off-Shores

Industry / Brazil Following in the footsteps of drug developers that are recognising the attraction of emerging markets as a base for clinical trials, Inventiv Health, a leading provider of clinical trials support services...
March 2008
Strides Latina's Slate Wiped Clean

Industry / Brazil India's Strides Arcolab and South Africa's Aspen Pharmacare have completed their tie-up, which gives Aspen a 50% stake in Strides' Latin American operations. Aspen injected US$152.5mn into Strides Latina...
March 2008
Strides Latina's Slate Wiped Clean

Industry / Brazil India's Strides Arcolab and South Africa's Aspen Pharmacare have completed their tie-up, which gives Aspen a 50% stake in Strides' Latin American operations. Aspen injected US$152.5mn into Strides Latina...
March 2008
Schering-Plough Ends Brazilian Joint Venture

Companies / Brazil US pharmaceuticals giant Schering-Plough has announced that its local partner Mantecorp will assume full ownership of their joint venture. Meanwhile, the US firm will establish a new wholly-owned subsidiary,...
June 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2009 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS